Clinical trial of cefoselis on community-acquired pneumonia.

Objective To evaluate the clinical efficacy and safety of injective cefoselis in the treatment of moderate to severe community-acquired pneumonia(CAP).Methods 41 patients with moderate to severe CAP were randomly divided into two groups,injective cefoselis was given in the observed group,ceftazidime in the controlled group.The course of treatment was 7-14d.Results The clinical effective rate of cefoselis group was 88.2%;the bacterial clearance rate was 85.7%.While that of ceftazidime group was 78.9% and 87.5% respectively.The incidence of adverse reaction of cefoselis group was 4.8%,that of ceftazidime group was 5.0%.Conclusion Cefoselis sulfate injection is more effective and safer than ceftazidime in treating moderate to severe CAP.